Skip to main content
CivicGate

HB 553 MO

Modifies provisions relating to epinephrine products

MO · session 2025 · Assembly / House · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced Dec 13, 2024

Latest action (Apr 10, 2025) Reported Do Pass (H) - AYES: 10 NOES: 0 PRESENT: 0

Sponsor (1)
1 coauthor / cosponsor

Action history (12)
  1. Dec 13, 2024 Prefiled (H) · lower
  2. Jan 8, 2025 Read First Time (H) · lower
  3. Jan 9, 2025 Read Second Time (H) · lower
  4. Jan 30, 2025 Referred: Health and Mental Health(H) · lower
  5. Mar 4, 2025 Public Hearing Completed (H) · lower
  6. Mar 11, 2025 Executive Session Completed (H) · lower
  7. Mar 11, 2025 Voted Do Pass (H) · lower
  8. Mar 12, 2025 Reported Do Pass (H) - AYES: 13 NOES: 0 PRESENT: 0 · lower
  9. Mar 24, 2025 Referred: Rules - Administrative(H) · lower
  10. Apr 10, 2025 Executive Session Completed (H) · lower
  11. Apr 10, 2025 Voted Do Pass (H) · lower
  12. Apr 10, 2025 Reported Do Pass (H) - AYES: 10 NOES: 0 PRESENT: 0 · lower
Subjects
DRUGS AND CONTROLLED SUBSTANCESELEMENTARY AND SECONDARY EDUCATION, DEPT. OFEMERGENCIESHEALTH CAREHEALTH CARE PROFESSIONALSNURSES

Text versions (1)

The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.

  • Introduced · PDF

Full text

The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.

Comments

Comments

Loading comments…

Data from OpenStates. View on OpenStates →